News Pan Cancer T Secures EUR 10 Million to Advance First-in-Human Trial of Novel TCR-T Cell Therapy for Triple-Negative Breast Cancer Pan Cancer T B.V., a biotech company pioneering next-generation T cell therapies for solid tumours,…Irene GebuisDecember 10, 2025
News DMEA Berlin With more than 20,500 participants, 900 exhibitors, 200 sessions and over 450 speakers, DMEA -…Irene GebuisDecember 9, 2025
News SkylineDx Wins 2025 BioTech Breakthrough Award for “Diagnostics Company of the Year” SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for…Irene GebuisDecember 4, 2025
News From Düsseldorf to Leiden: Driving Innovation in Life Sciences & Health! Last week, Sharon and Joelle attended MEDICA in Düsseldorf, one of the world’s leading trade…Irene GebuisNovember 28, 2025